COUTTS MULTI ASSET FUNDS GLOBAL
Coutts multi-asset funds are a range of global funds that aim to deliver attractive long-term returns by investing in a broad range of asset classes such as cash, bonds, equities, commodities and property.
Fourth Quarter 2016
Fund returns, after fees (GBP Class A - distributing) Defensive Balanced Growth Last Quarter -1.28% 0.80% 1.76% Rolling 12 Months: End Dec 15 to end Dec 16 5.55% 4.63% 3.80% End Dec 14 to end Dec 15 -1.10% -1.44% -1.13% End Dec 13 to end Dec 14 4.72% 4.48% 3.98% End Dec 12 to end Dec 13 - - - End Dec 11 to end Dec 12 - - - Blank cells represent periods prior to the Funds launch Source: Coutts/Thomson Datastream
Diversification through trend-following alternative strategies
With interest rates set to rise further in the US and expectations of higher inflation, the long-term return prospects for government bonds have deteriorated. As a result, we have been adding diversified sources of returns to portfolios that are uncorrelated with risky assets, such as equities, through two new alternative strategies:
The BMO Global Equity Market Neutral Fund seeks to generate a positive return through all market conditions. Its strategy involves investing in stocks that demonstrate one or more of five styles – value, momentum, size, low volatility, and growth at a reasonable price (GARP). The philosophy underpinning this approach is that a substantial amount of investment performance can be explained by these styles.
The JP Morgan Global Macro Fund seeks to generate an annualised return of 7% above interest rates over the medium term by investing across a broad range of asset classes. The fund’s diversified and flexible approach allows it to capture asymmetric opportunities (where there is greater upside than downside potential) through the business cycle. In addition, the managers use a dynamic hedging process to mitigate risk.
Attractive valuations in healthcare
We believe the healthcare sector presents an attractive long-term investment opportunity, where demographic trends should support strong and consistent earnings. Yet share prices had fallen in the months before the US election over concerns that drug prices could come under pressure if Hillary Clinton became president. We took advantage of the attractive valuations by adding one of two funds in this sector:
Polar Capital Healthcare Opportunities is managed by an experienced team with a strong track record and expertise in biochemistry and investing. They focus on identifying growth-oriented opportunities, predominantly in large-cap securities. But the fund has a strong tilt towards mid and small cap companies relative to its benchmark.
For more defensive portfolios we added the LGIM Global Health & Pharmaceuticals Index Trust, a passive fund that aims to track the performance of the FTSE Health and Pharmaceuticals Index. Given Polar’s concentrated fund has a relatively high tracking error (a measure of how much a fund’s returns diverge from the benchmark index), this more large-cap biased index-tracking option is seen as more suitable for defensive portfolios.
Increasing exposure to sterling
In the days following the Brexit result, sterling depreciated rapidly to multi-year lows against other major currencies. Although it remains depressed, we believe the pound’s valuation will move back in line with its long-term average in the months ahead. To take advantage of this expected appreciation, we are increasing our sterling exposure by:
Switching from the euro-denominated JO Hambro European Equity Fund to the hedged sterling share class. The managers behind this strategy combine their view of the global economy with fundamental company research to identify high-quality businesses. With a long-standing investment team and consistent returns, we see this fund as a core portfolio holding.
Adding a new position in the Pimco Global Investment Grade Fund, also denominated in sterling. This strategy invests predominantly in global investment grade corporate bonds. We like the experienced investment team’s focus on strong company fundamentals, attractive valuations and industry sectors that are likely to benefit from prevailing economic trends.
Value investing in Japan
We initiated a new position in the GLG Man Japan Core Alpha Equity Fund to provide active exposure to Japan’s stock market. The managers follow a contrarian approach by investing in large-cap Japanese companies with strong management teams that are undervalued – typically because they are out of favour with the rest of the market. This strategy is consistent with our own investment philosophy, and we have confidence in the managers’ repeatable process and successful track record.
Early in the quarter we added healthcare, and also several trend-following hedge fund strategies. This was done largely at the expense of government bonds and also reduced our previously high cash weightings substantially in client portfolios, from about 9% to 3% in a typical balanced portfolio. We believe these strategies have limited correlation to equity markets, providing diversification benefits while also offering higher potential returns than government bonds.
In December, we took profits on overseas assets that have delivered strong returns (boosted by sterling weakness in the aftermath of the Brexit result) and repatriated those proceeds into sterling-denominated assets. Our analysis suggests sterling’s valuation should move higher from current historically low levels, back in line with its long-term average in the months ahead.
Summary of moves
- Exposure added to the healthcare sector at what we believe were attractive valuations. Added alternative strategies that can provide similar diversification benefits to government bonds, but where we see greater return potential.
- Took profit on overseas assets that had benefited from sterling weakness and increased exposure to sterling-denominated assets given our forecast that the pound would appreciate
(Please note: not all moves will be relevant for all funds)
27-Feb-2023As the new tax year approaches, you might want to know about possible changes to what you’ll pay in tax. In his Autumn Statement last November, Chancellor Jeremy Hunt announced a series of tax freezes and adjustments. While there are no personal tax rises, the fact that some rates have been frozen following a year of rising prices means we’re likely see more people fall into the higher rate category and find themselves paying more tax as wages increase.